These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9200472

  • 1. Differential CD45 isoform expression accompanies reduced natural antibody binding in L5178Y-F9 tumor progression.
    Zhang ZY, Chow DA.
    J Immunol; 1997 Jul 01; 159(1):344-50. PubMed ID: 9200472
    [Abstract] [Full Text] [Related]

  • 2. Polyclonal natural antitumor antibody binding dynamics: preferential release of surface membrane molecules and increased metastasis.
    Chow DA, Yuan XY, Tough DF.
    Invasion Metastasis; 1992 Jul 01; 12(3-4):218-32. PubMed ID: 1294533
    [Abstract] [Full Text] [Related]

  • 3. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
    Chow DA.
    J Natl Cancer Inst; 1984 Feb 01; 72(2):339-46. PubMed ID: 6582320
    [Abstract] [Full Text] [Related]

  • 4. Tumorigenicity of murine lymphomas selected through fluorescence-detected natural antibody binding.
    Tough DF, Chow DA.
    Cancer Res; 1988 Jan 15; 48(2):270-5. PubMed ID: 3335005
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic alterations in tumors that developed from threshold subcutaneous inocula. I. Reduced binding of natural antibodies and sensitivity to hypotonic lysis.
    Brown GW, Lesiuk TP, Chow DA.
    J Immunol; 1986 Apr 15; 136(8):3116-23. PubMed ID: 3958491
    [Abstract] [Full Text] [Related]

  • 6. p21ras independent down-regulation of ras-induced increases in natural antibody binding during tumor progression.
    Tough DF, Feng X, Chow DA.
    Nat Immun; 1995 Apr 15; 14(1):20-34. PubMed ID: 7599459
    [Abstract] [Full Text] [Related]

  • 7. Tumor progression in vitro: the paradoxical natural antibody and complement-selected phenotype.
    Chow DA, Chan J.
    Nat Immun Cell Growth Regul; 1987 Apr 15; 6(4):189-204. PubMed ID: 3683415
    [Abstract] [Full Text] [Related]

  • 8. Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages.
    Zapata JM, Pulido R, Acevedo A, Sánchez-Madrid F, de Landázuri MO.
    J Immunol; 1994 Apr 15; 152(8):3852-61. PubMed ID: 8144955
    [Abstract] [Full Text] [Related]

  • 9. Phorbol ester tumor promoter regulation of natural antitumor antibody binding depends on protein kinase C and an intact microfilament system.
    Sandstrom PA, Chow DA.
    Nat Immun; 1994 Apr 15; 13(6):331-43. PubMed ID: 7894203
    [Abstract] [Full Text] [Related]

  • 10. Inverse correlation between natural antitumor antibodies and tumor susceptibility in individual xid-bearing mice.
    Bennet RD, Chow DA.
    Nat Immun Cell Growth Regul; 1991 Apr 15; 10(1):45-55. PubMed ID: 2057021
    [Abstract] [Full Text] [Related]

  • 11. Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70.
    Grohmann U, Ullrich SJ, Mage MG, Appella E, Fioretti MC, Puccetti P, Romani L.
    Eur J Immunol; 1990 Mar 15; 20(3):629-36. PubMed ID: 2318253
    [Abstract] [Full Text] [Related]

  • 12. Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance.
    Miller VE, Pohajdak B, Greenberg AH.
    J Natl Cancer Inst; 1983 Aug 15; 71(2):377-84. PubMed ID: 6576195
    [Abstract] [Full Text] [Related]

  • 13. The regulatory role of CD45 on rat NK cells in target cell lysis.
    Giezeman-Smits KM, Gorter A, van Vlierberghe RL, v Eendenburg JD, Eggermont AM, Fleuren GJ, Kuppen PJ.
    J Immunol; 1999 Jul 01; 163(1):71-6. PubMed ID: 10384101
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel CD8 T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation.
    Carlow DA, Ardman B, Ziltener HJ.
    J Immunol; 1999 Aug 01; 163(3):1441-8. PubMed ID: 10415045
    [Abstract] [Full Text] [Related]

  • 16. Natural antibody recognition of v-H-ras-induced 10T1/2 transformation.
    Tough DF, Chow DA.
    Nat Immun Cell Growth Regul; 1991 Aug 01; 10(2):83-93. PubMed ID: 1652685
    [Abstract] [Full Text] [Related]

  • 17. Genetics of natural antitumor antibody production: antibodies to MHC-linked determinants detected in the serum of unstimulated mice.
    Wolosin LB, Greenberg AH.
    J Immunol; 1981 Apr 01; 126(4):1456-9. PubMed ID: 6162890
    [Abstract] [Full Text] [Related]

  • 18. The leukocyte common antigen (CD45) on human pre-B leukemia cells: variant glycoprotein form expression during the cell exposure to phorbol ester is blocked by a nonselective protein kinase inhibitor H7.
    Duraj J, Sedlák J, Rauko P, Chorváth B.
    Neoplasma; 1997 Apr 01; 44(4):205-11. PubMed ID: 9473774
    [Abstract] [Full Text] [Related]

  • 19. CD45 isoform RB as a molecular target to oppose lipopolysaccharide-induced microglial activation in mice.
    Townsend KP, Vendrame M, Ehrhart J, Faza B, Zeng J, Town T, Tan J.
    Neurosci Lett; 2004 May 13; 362(1):26-30. PubMed ID: 15147773
    [Abstract] [Full Text] [Related]

  • 20. Targeting CD45RB alters T cell migration and delays viral clearance.
    Lim B, Sutherland RM, Zhan Y, Deliyannis G, Brown LE, Lew AM.
    Int Immunol; 2006 Feb 13; 18(2):291-300. PubMed ID: 16361310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.